Roth Capital Downgrades Obagi Medical Products (OMPI) to Neutral
Tweet
Share
E-mailGet Alerts OMPI Hot Sheet
Price: $23.98 --0%
Rating Summary:
0 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
0 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Roth Capital downgraded Obagi Medical Products (NASDAQ: OMPI) from Buy to Neutral. PT lowered from $16 to $13.50.
For more ratings news on Obagi Medical Products click here and for the rating history of Obagi Medical Products click here.
Shares of Obagi Medical Products closed at $12.90 yesterday.
For more ratings news on Obagi Medical Products click here and for the rating history of Obagi Medical Products click here.
Shares of Obagi Medical Products closed at $12.90 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Downgrades Accelerant Holdings (ARX) to Sector Perform
- JPMorgan Downgrades HomeCo Daily Needs REIT (HDN:AU) to Neutral
- HSBC Downgrades Cisco (CSCO) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
